Clinical Trial Update: Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toripalimab with induction chemotherapy and radiation therapy including omega-3 for locally advanced nasopharyngeal carcinoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Affiliated Hospital of Guangdong Medical University | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 2 | Status: NOT_YET_RECRUITING